265 related articles for article (PubMed ID: 34019594)
1. Modulation of inflammatory responses by fractalkine signaling in microglia.
Inoue K; Morimoto H; Ohgidani M; Ueki T
PLoS One; 2021; 16(5):e0252118. PubMed ID: 34019594
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH.
Chen X; He X; Xu F; Xu N; Sharifi NH; Zhang P; Flores JJ; Wu L; He Q; Kanamaru H; Zhu S; Dong S; Han M; Yuan Y; Huang L; Miao L; Zhang JH; Zhou Y; Tang J
Stroke; 2023 Sep; 54(9):2420-2433. PubMed ID: 37465997
[TBL] [Abstract][Full Text] [Related]
3. FKN/CX3CR1 axis facilitates migraine-Like behaviour by activating thalamic-cortical network microglia in status epilepticus model rats.
Zhou Y; Zhang L; Hao Y; Yang L; Fan S; Xiao Z
J Headache Pain; 2022 Apr; 23(1):42. PubMed ID: 35382731
[TBL] [Abstract][Full Text] [Related]
4. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Xu MX; Yu R; Shao LF; Zhang YX; Ge CX; Liu XM; Wu WY; Li JM; Kong LD
Brain Behav Immun; 2016 Nov; 58():69-81. PubMed ID: 26765996
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of Fractalkine on Radiation-induced Brain Injury Through Promoting the M2 Polarization of Microglia.
Wang J; Pan H; Lin Z; Xiong C; Wei C; Li H; Tong F; Dong X
Mol Neurobiol; 2021 Mar; 58(3):1074-1087. PubMed ID: 33089423
[TBL] [Abstract][Full Text] [Related]
6. Concentration and proteolysis of CX3CL1 may regulate the microglial response to CX3CL1.
Finneran D; Li Q; Subbarayan MS; Joly-Amado A; Kamath S; Dengler DG; Gordon MN; Jackson MR; Morgan D; Bickford PC; Smith LH; Nash KR
Glia; 2023 Feb; 71(2):245-258. PubMed ID: 36106533
[TBL] [Abstract][Full Text] [Related]
7. The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.
Pawelec P; Ziemka-Nalecz M; Sypecka J; Zalewska T
Cells; 2020 Oct; 9(10):. PubMed ID: 33065974
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1
Church KA; Rodriguez D; Mendiola AS; Vanegas D; Gutierrez IL; Tamayo I; Amadu A; Velazquez P; Cardona SM; Gyoneva S; Cotleur AC; Ransohoff RM; Kaur T; Cardona AE
Front Immunol; 2023; 14():1130735. PubMed ID: 37033925
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease.
Camacho-Hernández NP; Peña-Ortega F
Neural Plast; 2023; 2023():4637073. PubMed ID: 36644710
[TBL] [Abstract][Full Text] [Related]
10. Microglia Mediate HIV-1 gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits.
Ru W; Liu X; Bae C; Shi Y; Walikonis R; Mo Chung J; Tang SJ
J Neurosci; 2019 Oct; 39(42):8408-8421. PubMed ID: 31471472
[TBL] [Abstract][Full Text] [Related]
11. Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge.
Wynne AM; Henry CJ; Huang Y; Cleland A; Godbout JP
Brain Behav Immun; 2010 Oct; 24(7):1190-201. PubMed ID: 20570721
[TBL] [Abstract][Full Text] [Related]
12. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
Szukiewicz D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
[TBL] [Abstract][Full Text] [Related]
13. Fractalkine/CX3CR1 signalling in chronic pain and inflammation.
Clark AK; Staniland AA; Malcangio M
Curr Pharm Biotechnol; 2011 Oct; 12(10):1707-14. PubMed ID: 21466443
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways.
Ma B; Xu L; Pan X; Sun L; Ding J; Xie C; Koliatsos VE; Cai H
Hum Mol Genet; 2016 Aug; 25(16):3515-3523. PubMed ID: 27378696
[TBL] [Abstract][Full Text] [Related]
15. CX3CR1-microglia mediates neuroinflammation and blood pressure regulation in the nucleus tractus solitarii of fructose-induced hypertensive rats.
Ho CY; Lin YT; Chen HH; Ho WY; Sun GC; Hsiao M; Lu PJ; Cheng PW; Tseng CJ
J Neuroinflammation; 2020 Jun; 17(1):185. PubMed ID: 32532282
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine aggravates LPS-induced macrophage activation and acute kidney injury via Wnt/β-catenin signalling pathway.
Gong Q; Jiang Y; Pan X; You Y
J Cell Mol Med; 2021 Jul; 25(14):6963-6975. PubMed ID: 34101346
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide-induced maternal immune activation modulates microglial CX3CR1 protein expression and morphological phenotype in the hippocampus and dentate gyrus, resulting in cognitive inflexibility during late adolescence.
Fernández de Cossío L; Lacabanne C; Bordeleau M; Castino G; Kyriakakis P; Tremblay MÈ
Brain Behav Immun; 2021 Oct; 97():440-454. PubMed ID: 34343619
[TBL] [Abstract][Full Text] [Related]
18. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
[TBL] [Abstract][Full Text] [Related]
19. Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.
Cardona SM; Mendiola AS; Yang YC; Adkins SL; Torres V; Cardona AE
ASN Neuro; 2015; 7(5):. PubMed ID: 26514658
[TBL] [Abstract][Full Text] [Related]
20. Potential role of the hydroxyl carboxylic acid receptor type 2 (HCAR2) in microglia pathophysiology: A possible cross-talk with C-X-C chemokine receptor 1 (CXCR1).
Perrone M; Pagano M; Belardo C; Ricciardi F; Ricciardi F; Fusco A; Trotta MC; Infantino R; Gargano F; Parente A; Giacca R; Pieretti G; Luongo L; Maione S; Boccella S; Guida F
Neuropharmacology; 2023 May; 228():109456. PubMed ID: 36796675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
